Stay updated on Zephyrus I Clinical Trial
Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.

Latest updates to the Zephyrus I Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedMinor layout changes to the study locations section with no alterations to core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedCore content updated with government funding status and operating guidance plus a new software version (v3.2.0) replacing the old v3.0.2.SummaryDifference2%

- Check45 days agoChange DetectedRemoved major drug-safety and quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), significantly reducing core content about drug quality and safety.SummaryDifference0.2%

- Check53 days agoChange Detected- The page now shows a new revision label: v3.0.2, replacing v3.0.1. - A stray “Back to Top” item was removed. Overall, this is a minor update focused on versioning and a small UI change, with no impact on core content, pricing, or availability.SummaryDifference0.1%

- Check60 days agoChange DetectedVersion updated from v3.0.0 to v3.0.1, and a 'Back to Top' link has been added. Core content, pricing, stock, and time-slot data remain unchanged.SummaryDifference0.1%

- Check74 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the inclusion of new medical resources related to interstitial lung disease and drug safety. Notably, previous entries for certain locations and resources have been removed.SummaryDifference14%

Stay in the know with updates to Zephyrus I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.